HeartFlow
Non-invasive precision coronary care using computer-aided analysis of coronary arteries.
What they do
The company utilizes deep learning and computed tomography data to construct personalized 3D models of patients' coronary arteries. This allows clinicians to analyze blood flow restriction and diagnose coronary artery disease without invasive procedures.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Cardiovascular diagnostics
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Mountain View, USA
- Region
- North America
- Founded
- 2007
- Total funding
- $640M raised
Notable investors: Baillie Gifford, Fidelity, Sands Capital, BlueCross BlueShield Venture Partners.